ERNIE-评估脑肿瘤儿童个体化神经心理干预反应:随机对照试验研究方案
ERNIE研究是在荷兰Princess Máxima儿童肿瘤中心开展的单中心、前瞻性、优效性随机对照试验,计划招募144名8至17岁完成脑肿瘤治疗后存在认知问题的儿童,按1:1随机分配至个体化或标准化神经心理干预(各6次、历时3个月),主要结局为干预后目标达成量表(GAS),并同步进行过程评价。
要点
- 研究对象为8至17岁完成脑肿瘤治疗后存在认知问题的儿童,计划招募144人,2024年11月开始入组,持续两年。
- 个体化与标准化神经心理干预各含6次心理教育和策略训练,历时3个月,按年龄和认知障碍程度分层随机。
- 主要结局为干预后通过患者和家长访谈评估的目标达成量表(GAS),随访约12个月。
核心结论
- 研究旨在比较个体化与标准化神经心理干预在治疗结束后即刻的疗效,并通过整合结局评估与过程评价,生成疗效与实施可行性的证据,可能有助于塑造未来临床实践。
研究设计与样本
- 单中心、前瞻性、优效性随机对照试验,在荷兰Princess Máxima儿童肿瘤中心开展。
- eligible participants为8至17岁完成脑肿瘤治疗后存在认知问题的儿童,2024年11月开始入组,持续两年,计划招募144名参与者。
- 参与者及家长按1:1随机分配至个体化或标准化神经心理干预,各含6次心理教育和策略训练,历时3个月。
- 随机化按年龄(8-12岁/13-17岁)和认知障碍(轻度/重度)分层。
- 结局评估者和家庭对分组设盲,治疗师因干预性质无法设盲。
主要发现
- 主要结局为干预后通过患者和家长访谈评估的目标达成量表(GAS)。
- 其他结局包括目标满意度、认知与心理社会结局,以及干预过程指标,包括招募可行性、干预完成、数据收集及实施因素(如促进因素和障碍)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although survival rates for children with brain tumors have improved, many face neuropsychological challenges that can affect quality of life and daily functioning. Existing interventions are typically standardized, with limited evidence supporting their effectiveness, and often do not explicitly target individual or systemic needs. The ERNIE study aims to address these gaps by evaluating the efficacy and process of an individualized, family-centered neuropsychological intervention. The primary research question is to evaluate the efficacy of an individualized versus standardized neuropsychological intervention immediately after treatment completion. METHODS: The ERNIE study is a single-center, prospective, superiority randomized controlled trial at the Princess Máxima Center for Pediatric Oncology in the Netherlands. Eligible participants are children aged 8 to 17 years with cognitive problems following completion of brain tumor treatment. Enrollment began in November 2024 and will continue for two years, with the study team aiming to recruit 144 participants. Participants and parents are randomly assigned (1:1) to an individualized or a standardized neuropsychological intervention, each comprising six sessions of psychoeducation and strategy training over three months. Randomization is stratified by age (8-12/13-17 years) and cognitive impairment (mild/severe). Outcome assessors and families are blinded to allocation, whereas therapists cannot be blinded due to the nature of the intervention. The primary outcome is Goal Attainment Scaling (GAS), assessed through a patient and parent interview post-intervention. Other outcomes are goal satisfaction, cognitive and psychosocial outcomes, and measures of the intervention process, including recruitment feasibility, intervention completion, data collection, and implementation factors such as facilitators and barriers. A six-month internal pilot will provide an early assessment to inform study procedures. Assessments occur pre-intervention, post-intervention (~ 3 months), and follow-up (~ 12 months). Safety monitoring aligns with low-risk studies. DISCUSSION: The ERNIE study compares an individualized neuropsychological approach with a standardized approach. By integrating outcome assessment with process evaluation, the study seeks to generate evidence on both efficacy and implementation feasibility. Findings may help shape future clinical practices by investigating the impact of individualized neuropsychological interventions to improve daily functioning in this vulnerable group of children. TRIAL REGISTRATION: ISRCTN trial registry ISRCTN30985676, registered on 04 October 2024. https://www.isrctn.com/ISRCTN30985676 .
引用
- Hofman R, Kemps R, Voorman JM, et al. ERNIE-Evaluating Response to an individualized Neuropsychological IntervEntion for children with brain tumors: study protocol for a randomized controlled trial. Trials. 2026. PMID: 41514361. doi:10.1186/s13063-025-09420-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。